Table 2.
Key factors and pathways in the pathogenesis of diabetic kidney disease
Haemodynamic | ||
Prostanoids | Nitric oxide | |
Renin–angiotensin–aldosterone system | ||
Vascular endothelial growth factor (VEGF) | ||
Transforming growth factor (TGF)-β1 | ||
Metabolic | ||
Glucose transporters: GLUT-1, GLUT-4, glucokinase/hexokinase. | ||
Advanced glycation end products and their receptors | ||
Aldose reductase | Protein kinase C | |
Diacylglyerol | UDP-N-acetylglucosamine | |
NADPH oxido-reductase | Oxidative stress | |
TGF-β–Smad–mitogen-activated protein kinase (TGF-β–Smad–MAPK) | ||
Janus kinase–signal transducer and activator of transcription (JAK-STAT) | ||
Growth factors | ||
VEGF | TGF-β1 | Connective tissue growth factor |
Inflammation | ||
Chemokines: monocyte chemoattractant protein-1 | ||
Adhesion molecules: intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1). | ||
Inflammatory cytokines: interleukin-1, -6, -18, and tumour necrosis factor-α | ||
Transcription factors: nuclear transcription factor κ-B (NF-κB) |